Danske Bank’s Sotera Health SHC Stock Holding History

Danske Bank’s Portfolio SHC Stock Details SHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-581,140	Closed	-$8.33M	–	1212
2026 Q1	$8.33M	Buy	+581,140	New	+$9.65M	0.02%	467
2024 Q4	–	Sell	-69,280	Closed	-$1.16M	–	1619
2024 Q3	$1.16M	Buy	+69,280	New	+$1.01M	﹤0.01%	790

Other funds holding SHC

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

DCP

Darsana Capital Partners New York $22.3B AUM 42.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Danske Bank's SHC Position: Q2 2026 in Review

Danske Bank sold out of Sotera Health (SHC) in Q2 2026, closing a stake of 581,140 shares — an estimated $8.33M sold.

Danske Bank first reported a position in SHC in Q3 2024 and held it in 2 quarters. The position peaked at $8.33M in Q1 2026. 316 funds tracked by Wall St. Rank hold SHC as of Q2 2026.

Danske Bank reported no remaining Sotera Health position as of Q2 2026 after selling out during the quarter.
Danske Bank sold 581,140 Sotera Health shares in Q2 2026, an estimated $8.33M.
Danske Bank first reported a position in Sotera Health in Q3 2024 and held it in 2 quarters.
Danske Bank's Sotera Health position peaked at $8.33M in Q1 2026.
316 funds tracked by Wall St. Rank held Sotera Health as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.